CompletedPhase 1

A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes

NCT03322631

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.

Hachiōji, Tokyo, Japan

+1 additional location

View on ClinicalTrials.gov